Cargando...
New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review
INTRODUCTION: In the last 20 years, biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) have become available for treating rheumatoid arthritis (RA), and a treat-to-target strategy has been introduced. We hypothesise that these advances should have resulted in changes to t...
Gardado en:
| Publicado en: | Adv Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Healthcare
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444401/ https://ncbi.nlm.nih.gov/pubmed/32705531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01435-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|